Focussing on pharma’s blind spot
January 4, 2022
Industry’s free pass to its target audience has been shredded by the pandemic leaving the sales force compass struggling to find effective routes.
It has exposed a blind spot that was previously covered by engagement success rates and comfortable repeat business. Only now are we seeing the downside of a lack of finesse along the pathway from strategic sales conferences to client meetings.
Read the source article at pharmaphorum.com
2021-12-20 14:58:14